netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Results

Looking for Aflibercept found 8 matches

Open monograph to display formulary status BNF Category
  Aflibercept  (Eylea) Eye - Subfoveal choroidal neovascularisation - 11.08.02
  Cytotoxic Drug Aflibercept  (Zaltrap) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01.05)
link in drug section NICE TA409:Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (Sep 2016) (11.08.02)
link in drug section NICE TA486:Aflibercept for treating choroidal neovascularisation (Nov 2017) (11.08.02)
link in drug section Use as per NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (July 2013) (11.08.02)
link in drug section Use as per NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion(February 2014) (11.08.02)
link in drug section Use as per NICE TA346: Aflibercept for treating diabetic macular oedema (July 2015) (11.08.02)


 

netFormulary